Nanoviricides Inc (NNVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 1,811 | 1,834 | 1,622 | 1,793 | 1,788 |
| Operating Income | -1,811 | -1,834 | -1,622 | -1,793 | -1,788 |
| Interest Expense | 0 | 0 | 1 | -3 | 5 |
| Other Income | 108 | 89 | 53 | 10 | 0 |
| Pre-tax Income | -1,703 | -1,745 | -1,571 | -1,780 | -1,793 |
| Net Income Continuous | -1,703 | -1,745 | -1,571 | -1,780 | -1,793 |
| Net Income | $-1,703 | $-1,745 | $-1,571 | $-1,780 | $-1,793 |
| EPS Basic Total Ops | -0.15 | -0.15 | -0.14 | -0.14 | -0.16 |
| EPS Basic Continuous Ops | -0.15 | -0.15 | -0.14 | -0.15 | -0.16 |
| EPS Diluted Total Ops | -0.15 | -0.15 | -0.14 | -0.14 | -0.16 |
| EPS Diluted Continuous Ops | -0.15 | -0.15 | -0.14 | -0.15 | -0.16 |
| EBITDA(a) | $-1,622 | $-1,647 | $-1,439 | $-1,605 | $-1,606 |